Anti-SARS-CoV-2 Antibody Development over Four Years in Blood Donors

The blood donor population has great potential to serve as a sentinel system for the general population. The data presented in this study of a survey of the seroprevalence of Anti-SARS-CoV-2 antibodies in Switzerland are an illustrative example of this possibility. From March 2020 to January 2021, t...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Viruses Jg. 17; H. 10; S. 1292
Hauptverfasser: Niederhauser, Christoph, Widmer, Nadja, Tinguely, Caroline, Suter Riniker, Franziska, Fontana, Stefano, Buser, Andreas, Waldvogel, Sophie, Thierbach, Jutta, Züger, Max, Gowland, Peter
Format: Journal Article
Sprache:Englisch
Veröffentlicht: Switzerland MDPI AG 24.09.2025
Schlagworte:
Adult
Aged
anti-NCP
anti-S
Antibodies
Antibodies, Viral - blood
Blood & organ donations
Blood donors
Blood Donors - statistics & numerical data
Coronavirus Nucleocapsid Proteins - immunology
COVID-19 - epidemiology
COVID-19 - immunology
COVID-19 vaccines
Epidemics
Ethics
Ethylenediaminetetraacetic acid
Female
Germany
Humans
Immunoassay
Infection
Infections
Infectious diseases
Male
Middle Aged
Pandemics
Phosphoproteins
Proteins
SARS-CoV-2 - immunology
SARS-CoV-2 virus 1
Seroepidemiologic Studies
Serology
seroprevalence epidemiology
Severe acute respiratory syndrome coronavirus 2
Spike Glycoprotein, Coronavirus - immunology
Switzerland
Switzerland - epidemiology
Vaccination
Viral antibodies
Young Adult
Switzerland
Germany
blood donors
anti-S
seroprevalence epidemiology
SARS-CoV-2 virus 1
anti-NCP
ISSN:1999-4915, 1999-4915
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The blood donor population has great potential to serve as a sentinel system for the general population. The data presented in this study of a survey of the seroprevalence of Anti-SARS-CoV-2 antibodies in Switzerland are an illustrative example of this possibility. From March 2020 to January 2021, the increase in antibody seroprevalence for both Anti-NCP and Anti-S was only very moderate, up to ~17%. In May/June 2021, the Anti-NCP seroprevalence was 21.6% and the S-seroprevalence 59.4%, respectively, indicating only a moderate natural infection rate. The Anti-seroprevalence rate was in good agreement with the first vaccination campaign launched in winter 2020/21. The dramatic increase in the antibodies against the NCP protein (74.6%) since November/December 2021 to June–August 2022 was simultaneous with the appearance and rapid spread of the Omicron SARS-CoV-2 variant in Switzerland and the abolition of compulsory mask wearing in public spaces. At the end of 2022, 99.0% of the blood donor population already developed antibodies against the S protein and 83.9% against the NCP. One year later, after the official termination of the pandemic, these seroprevalences were even higher, 99.8% for the Anti-S and 95.0% for Anti-NCP. This increase for both of them was in accordance with the vaccination campaigns, the abolition of mask wearing, and the spread of the Omicron variant. These data show how the blood donor population can be used to represent the infection surveillance of the general population of a region or country.
Bibliographie:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:1999-4915
1999-4915
DOI:10.3390/v17101292